Faculty

Institution

Unit

Venue

Sachin Apte

Chief Clinical Officer Professor of Obstetrics and Gynecology

University of Utah

Affiliations

School of Medicine

Department of Obstetrics and Gynecology

Division of Gynecologic Oncology

Sachin Apte is currently serving as an Obstetrics And Gynecology Chief Clinical Officer Professor of Obstetrics and Gynecology at University of Utah.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Sachin Apte

University of Utah

Chief Clinical Officer Professor of Obstetrics and Gynecology

You can click a keyword to filter the displayed items

oncology gynecologic oncology cancer research gynecology ovarian cancer cancer biology cancer treatment cancer care molecular biology radiation oncology tumor biology gynecologic cancers medicine cancer management medicinal research obstetrics and gynaecology surgical oncology cancer genomics oncogenes gene expression cancer immunotherapy anti-cancer agents cancer discovery cancer cells therapeutic targets enzyme inhibition tumor targeting cancer genetics pharmacotherapy cellular therapy microrna detection rna biology obstetrics gynecological surgery cell death epidemiology of cancer apoptosis tumor suppressors drug targeting operative treatment postoperative treatment therapeutic efficacy target messenger rnas ovarian cancer response recurrent ovarian cancer phase ii trial inflammatory biomarkers gynecologic malignancies therapeutic dilemma neuroscience of aging reproductive medicine plant science urogynecology biomarker target clinical conundrum clinical neurology disease progression aging-associated diseases chemoprevention strategies cancer growth novel therapies peripheral nerve food mycology cancer prevention genetic basis oncogenic agent tumor heterogeneity uterine neoplasms endometrial carcinogenesis uterine sarcoma novel natural substance bad-mediated apoptotic pathway human cancer development overall patient survival vitro analysis longitudinal examination outcomes research experimental medicine clinical endpoint surgical quality

Notable Scholarly Works

Notable Federal Grants

Collaborators

Data From Bad Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival. (2023)

Douglas C. MarchionHope M. CottrillYin XiongNing ChenElona BicakuWilliam J. FulpNisha BansalHye Sook ChonXiaomang B. SticklesSiddharth G. KamathArdeshir HakamLihua LiDan SuCarolina MorenoPatricia L. JudsonAndrew BerchuckRobert M. WenhamSachin M. ApteJesus Gonzalez-BosquetGregory C. BloomSteven A. EschrichSaid SebtiDung-Tsa ChenJohnathan M. Lancaster

pharmacologycancer carecancer researchsurvival analysisgeneticspatient survivalbiostatisticsoncologytherapeutic efficacycancer biologytumor biologyovarian cancer

Relationships Among Inflammatory Biomarkers and Objectively Assessed Physical Activity and Sleep During and After Chemotherapy for Gynecologic Malignancies. Cancers (2023)

DB TometichAI HooglandBJ SmallMC JanelsinsC Bryant...

medicinesleep medicinecancer careradiation oncologycancer researchgynecologic oncologyphysical activitysleeponcologycancer treatmentcancer biologyassessed physical activitygynecologic malignancieshealth sciencesinflammatory biomarkersinflammation

Relationships Among Inflammatory Biomarkers and Self-Reported Treatment-Related Symptoms in Patients Treated With Chemotherapy for Gynecologic Cancer: A Controlled Comparison. Cancers (2023)

AI HooglandBJ SmallLB OswaldC BryantY RodriguezBD Gonzalez...

medicineoutcomes researchcancer careradiation oncologycancer researchgynecologic oncologybenchmark studiespatient-reported outcomesgynecologic cancersoncologycontrolled comparisoncancer treatmenthealth sciencesinflammatory biomarkersinflammation

Supplementary Figure 1 From Bad Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival. (2023)

patient survivaloncologycancer biologygynecologyovarian cancer

Cumulative Burden of Symptomatology in Patients With Gynecologic Malignancies Undergoing Chemotherapy.. Health Psychology (2022)

LB OswaldSL EiselDB TometichC BryantAI HooglandBJ Small...

human healthhealth care costssurvival analysispsychological medicinepublic healthcancer carecancer managementhealth scienceshealth policysurgical oncologyhealth psychologycancer treatmentgynecologic malignanciescumulative burdenmental healthhealth carehealth outcomesoncologyrespiratory medicineintensive care

Utilizing Digital Pathology to Quantify Stromal Caveolin-1 Expression in Malignant and Benign Ovarian Tumors: Associations With Clinicopathological Parameters and Clinical Outcomes. PLoS ONE (2021)

Daryoush Saeed-VafaDouglas C. MarchionSusan M. McCarthyArdeshir HakamAlexis LopezRobert M. WenhamSachin M. ApteDung-Tsa ChenAnthony M. MaglioccoJohnathan M. LancasterBrett M. ReidJennifer B. Permuth

clinical outcomesbenign ovarian tumorsdigital pathologyclinicopathological parameterspathologyovarian cancer

Dual Antibiotic Prevention Bundle is Associated With Decreased Surgical Site Infections. International Journal of Gynecological Cancer (2020)

Michelle KuznickiAdrianne MallenEmily Clair McClungSharon E RobertsonSarah ToddDavid BoulwareStacy MartinRod QuilitzRoberto J VargasSachin M Apte

gynecologic oncologygynecologic cancersgynecologyoncology

Society of Gynecologic Oncology Future of Physician Payment Reform Task Force: Lessons Learned in Developing and Implementing Surgical Alternative Payment Models. Gynecologic Oncology (2020)

Margaret I. LiangEmeline M. AvikiJason D. WrightLaura J. HavrileskyLeslie R. BoydHaley A. MossElizabeth L. JewellDavid E. CohnSachin M. AptePatrick F. TimminsRonald D. AlvarezJill RathbunElizabeth LipinskiSusan WhiteDorimar Siverio-MinardiEmily M. Ko

medical educationgynecologic oncologyclinical implementationhealth policy

High-Dose Intensity-Modulated Chemoradiotherapy in Vulvar Squamous Cell Carcinoma: Outcome and Toxicity. Gynecologic Oncology (2019)

Anupam RishiMadeline RollinsKamran A. AhmedDylan C. HuntPapri SarkarDaniel C. FernandezMitchel S. HoffmanSachin M. ApteMian M.K. ShahzadHye Sook ChonJing-Yi ChernRobert M. WenhamMichael E. Montejo

cancer carehigh-dose intensity-modulated chemoradiotherapyradiation oncologycancer researchgynecologic oncologyoncologycancer treatmentgynecology

Ntrk-1 Fusion in Endocervical Fibroblastic Malignant Peripheral Nerve Sheath Tumor Marking Eligibility for Larotrectinib Therapy: A Case Report. Gynecologic Oncology Reports (2019)

A.E. WellsA.M. MallenM.M. BuiD.R. ReedS.M. Apte

larotrectinib therapycancer researchtumor biologygynecologic oncologyperipheral nervegynecologic cancersoncologygynecology

1
2
3
4
5
6
7
10 / page

Sachin Apte

Chief Clinical Officer Professor of Obstetrics and Gynecology

University of Utah

Affiliations

School of Medicine

Department of Obstetrics and Gynecology

Division of Gynecologic Oncology

Sachin Apte is currently serving as an Obstetrics And Gynecology Chief Clinical Officer Professor of Obstetrics and Gynecology at University of Utah.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Sachin Apte

University of Utah

Chief Clinical Officer Professor of Obstetrics and Gynecology

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Data From Bad Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival. (2023)

pharmacologycancer carecancer researchsurvival analysisgeneticspatient survivalbiostatisticsoncologytherapeutic efficacycancer biologytumor biologyovarian cancer

Relationships Among Inflammatory Biomarkers and Objectively Assessed Physical Activity and Sleep During and After Chemotherapy for Gynecologic Malignancies. Cancers (2023)

DB TometichAI HooglandBJ SmallMC JanelsinsC Bryant...

Relationships Among Inflammatory Biomarkers and Self-Reported Treatment-Related Symptoms in Patients Treated With Chemotherapy for Gynecologic Cancer: A Controlled Comparison. Cancers (2023)

AI HooglandBJ SmallLB OswaldC BryantY RodriguezBD Gonzalez...

Supplementary Figure 1 From Bad Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival. (2023)

patient survivaloncologycancer biologygynecologyovarian cancer

Cumulative Burden of Symptomatology in Patients With Gynecologic Malignancies Undergoing Chemotherapy.. Health Psychology (2022)

LB OswaldSL EiselDB TometichC BryantAI HooglandBJ Small...

Utilizing Digital Pathology to Quantify Stromal Caveolin-1 Expression in Malignant and Benign Ovarian Tumors: Associations With Clinicopathological Parameters and Clinical Outcomes. PLoS ONE (2021)

Daryoush Saeed-VafaDouglas C. MarchionSusan M. McCarthyArdeshir HakamAlexis LopezRobert M. WenhamSachin M. ApteDung-Tsa ChenAnthony M. MaglioccoJohnathan M. LancasterBrett M. ReidJennifer B. Permuth

clinical outcomesbenign ovarian tumorsdigital pathologyclinicopathological parameterspathologyovarian cancer

Dual Antibiotic Prevention Bundle is Associated With Decreased Surgical Site Infections. International Journal of Gynecological Cancer (2020)

Michelle KuznickiAdrianne MallenEmily Clair McClungSharon E RobertsonSarah ToddDavid BoulwareStacy MartinRod QuilitzRoberto J VargasSachin M Apte

gynecologic oncologygynecologic cancersgynecologyoncology

Society of Gynecologic Oncology Future of Physician Payment Reform Task Force: Lessons Learned in Developing and Implementing Surgical Alternative Payment Models. Gynecologic Oncology (2020)

medical educationgynecologic oncologyclinical implementationhealth policy

High-Dose Intensity-Modulated Chemoradiotherapy in Vulvar Squamous Cell Carcinoma: Outcome and Toxicity. Gynecologic Oncology (2019)

Anupam RishiMadeline RollinsKamran A. AhmedDylan C. HuntPapri SarkarDaniel C. FernandezMitchel S. HoffmanSachin M. ApteMian M.K. ShahzadHye Sook ChonJing-Yi ChernRobert M. WenhamMichael E. Montejo

cancer carehigh-dose intensity-modulated chemoradiotherapyradiation oncologycancer researchgynecologic oncologyoncologycancer treatmentgynecology

Ntrk-1 Fusion in Endocervical Fibroblastic Malignant Peripheral Nerve Sheath Tumor Marking Eligibility for Larotrectinib Therapy: A Case Report. Gynecologic Oncology Reports (2019)

A.E. WellsA.M. MallenM.M. BuiD.R. ReedS.M. Apte

larotrectinib therapycancer researchtumor biologygynecologic oncologyperipheral nervegynecologic cancersoncologygynecology

1
2
3
4
5
6
7
10 / page

Similar Faculty Members

Bhavana Pothuri

Institution

New York University

gynecologic oncology

gynecology

Nelson Teng

Institution

Stanford University

gynecologic oncology

gynecology

Victoria Bae-Jump

Institution

University of North Carolina at Chapel Hill

gynecologic oncology

oncology

Bhuvaneswari Ramaswamy

Institution

Ohio State University

cancer letter

cancer treatment

Denise M Scholtens

Institution

Northwestern University

health sciences

oncology

Ronald D. Alvarez

Institution

Vanderbilt University

tumor targeting

gynecologic oncology

Seema Khan

Institution

Northwestern University

breast cancer

oncology

Pei Hui

Institution

Yale University

oncology

pathology

Seongho Kim

Institution

Wayne State University

data analysis

personalized medicine

Sharad Ghamande

Institution

Augusta University

gynecologic oncology

gynecology

Similar Faculty Members

Bhavana Pothuri

Institution

New York University

gynecologic oncology

gynecology

Nelson Teng

Institution

Stanford University

gynecologic oncology

gynecology

Victoria Bae-Jump

Institution

University of North Carolina at Chapel Hill

gynecologic oncology

oncology

Bhuvaneswari Ramaswamy

Institution

Ohio State University

cancer letter

cancer treatment

Denise M Scholtens

Institution

Northwestern University

health sciences

oncology

Ronald D. Alvarez

Institution

Vanderbilt University

tumor targeting

gynecologic oncology

Seema Khan

Institution

Northwestern University

breast cancer

oncology

Pei Hui

Institution

Yale University

oncology

pathology

Seongho Kim

Institution

Wayne State University

data analysis

personalized medicine

Sharad Ghamande

Institution

Augusta University

gynecologic oncology

gynecology